切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2023, Vol. 20 ›› Issue (07) : 743 -748. doi: 10.3877/cma.j.issn.1672-6448.2023.07.013

浅表器官超声影像学

基于中国甲状腺超声报告与数据系统分析超声在不同大小甲状腺结节中的诊断价值
李卫民, 陈军民, 黄艳丽, 范晓芳(), 韩文, 贾磊, 张俊超, 瞿辰   
  1. 214000 江苏无锡,江南大学附属医院超声科
    311199 浙江杭州,杭州市临平区中医院超声科
    210002 江苏南京,东部战区总医院(原八一医院)特诊科
    215163 江苏苏州,苏州高新区人民医院超声科
  • 收稿日期:2022-02-16 出版日期:2023-07-01
  • 通信作者: 范晓芳
  • 基金资助:
    无锡市妇幼健康适宜技术推广项目(FYTG202103); 杭州市卫生科技计划一般(B类)项目(B20230553)

Diagnostic value of Chinese thyroid imaging reporting and data system in thyroid nodules with different sizes

Weimin Li, Junmin Chen, Yanli Huang, Xiaofang Fan(), Wen Han, Lei Jia, Junchao Zhang, Chen Qu   

  1. Department of Ultrasound, Affiliated Hospital of Jiangnan university, Wuxi 214000, China
    Department of Ultrasound, Hangzhou Linping District Traditional Chinese Medicine Hospital, Hangzhou 311199, China
    Special Clinic, General Hospital of Eastern Theater Command, PLA, Nanjing 210002, China
    Department of Ultrasound, People's Hospital of Suzhou National New Hi-tech Industrial Zone, Suzhou 215163, China
  • Received:2022-02-16 Published:2023-07-01
  • Corresponding author: Xiaofang Fan
引用本文:

李卫民, 陈军民, 黄艳丽, 范晓芳, 韩文, 贾磊, 张俊超, 瞿辰. 基于中国甲状腺超声报告与数据系统分析超声在不同大小甲状腺结节中的诊断价值[J/OL]. 中华医学超声杂志(电子版), 2023, 20(07): 743-748.

Weimin Li, Junmin Chen, Yanli Huang, Xiaofang Fan, Wen Han, Lei Jia, Junchao Zhang, Chen Qu. Diagnostic value of Chinese thyroid imaging reporting and data system in thyroid nodules with different sizes[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 743-748.

目的

探讨中国甲状腺超声报告与数据系统(C-TIRADS)在不同大小甲状腺结节中的诊断价值。

方法

前瞻性选取2020年12月至2022年12月经手术病理证实的甲状腺结节患者1146例,共1247个结节,按结节的最大径将其分为A1组(<10 mm)、A2组(10~20 mm)和A3组(>20 mm),评估各组甲状腺结节的超声特征,并根据C-TIRADS对其进行评分和分类。采用MannWhitney U检验比较各组良恶性结节C-TIRADS评分的差异,根据病理结果构建各组C-TIRADS评分和分类诊断结节良恶性的受试者操作特征(ROC)曲线,确定最佳临界值,分析C-TIRADS对不同大小甲状腺结节良恶性的诊断效能。

结果

A1组良恶性结节的评分分别为2(1,3)分、3(2,3)分,A2组良恶性结节的评分分别为1(0,2)分、3(3,4)分,A3组良恶性结节的评分分别为0(0,1)分、3(2,3)分,各组甲状腺恶性结节的评分均高于良性结节,差异均具有统计学意义(Z=3.501、15.273、10.012,P均<0.001)。A1组、A2组和A3组C-TIRADS评分系统对应的ROC曲线下面积(AUC)分别为0.580、0.893和0.918,临界值分别为>2分、>1分和>1分,3组分类系统对应的AUC分别为0.625、0.877、0.918,临界值分别为>4B类、>4A类、>4A类。3组评分和分类的诊断敏感度和特异度一致,且随着结节直径的增加,敏感度逐渐降低,分别为96.43%、93.86%、77.17%,特异度逐渐增加,分别为30.64%、69.90%、94.12%。

结论

C-TIRADS对不同大小甲状腺结节的诊断效能有所不同,随着结节的增大,C-TIRADS对甲状腺结节的诊断价值也逐渐升高。

Objective

To assess the diagnostic value of the Chinese thyroid imaging reporting and data system (C-TIRADS) in thyroid nodules with different sizes.

Methods

A total of 1 146 patients with 1 247 thyroid nodules confirmed by surgical pathology were prospectively selected from December 2020 to December 2022. According to the maximum diameter of thyroid nodules measured by ultrasound, all the thyroid nodules were divided into A1 group (<10 mm), A2 group (10-20 mm), and A3 group (>20 mm). According to the C-TIRADS, the ultrasonic characteristics of thyroid nodules in each group were evaluated and scored. The Mann-Whitney U-test was used to compare the C-TIRADS scores of benign and malignant nodules among the groups. Receiver oeprating characteristic (ROC) analysis was performed to obtain the optimal cut-off values for scoring and classification. The diagnostic efficacy of C-TIRADS scoring and classification for thyroid nodules of different sizes was then analyzed.

Results

The scores of benign and malignant nodules were 2 (1, 3) and 3 (2, 3) in group A1, 1 (0, 2) and 3 (3, 4) in group A2, and 0 (0, 1) and 3 (2, 3) in group A3, respectively. The scores of thyroid malignant nodules in each group were significantly higher than those of benign nodules (Z=3.501, 15.273, and 10.012, respectively, P<0.001 for all). The area under the curve (AUC) of C-TIRADS scoring in groups A1, A2, and A3 was 0.580, 0.893, and 0.918, respectively, and the cut-off value was >2, >1, and >1, respectively. The AUC of C-TIRADS classification was 0.625, 0.877, and 0.918, respectively, and the cut-off value was >4B, >4A, and >4A, respectively. The corresponding sensitivity and specificity were consistent among the three groups, and as the diameter of the nodule increased, the sensitivity gradually decreased (96.43%, 93.86%, and 77.17%, respectively) and the specificity gradually increased (30.64%, 69.90%, and 94.12%, respectively).

Conclusion

C-TIRADS has different diagnostic value for thyroid nodules with different sizes. As the diameter of thyroid nodules increases, the diagnostic value of C-TIRADS for thyroid nodules increases as well.

表1 不同甲状腺大小组甲状腺结节的病理结果分布(个)
表2 不同甲状腺大小组甲状腺结节的阳性超声特征分布[个(%)]
表3 基于C-TIRADS评分系统各组良恶性甲状腺结节的超声评分比较[分,MQR)]
图1 女性患者,27岁,右侧甲状腺结节,最大径为4 mm,垂直位,实性,极低回声,边缘模糊,内见可疑微钙化,C-TIRADS评分5分,C-TIRADS分类为5类
图2 女性患者,43岁,左侧甲状腺结节,最大径为13 mm,非垂直位,实性,极低回声,边缘模糊,内见可疑微钙化,C-TIRADS评分4分,C-TIRADS分类为4C类
图3 女性患者,39岁,右侧甲状腺结节,最大径为28 mm,非垂直位,以实性为主,低回声,边缘不规则,内见可疑微钙化,C-TIRADS评分3分,C-TIRADS分类为4C类
图4 甲状腺结节总样本评分和分类诊断良恶性的受试者操作特征曲线 注:C-TIRADS为中国甲状腺超声报告与数据系统
图5 各组甲状腺结节评分和分类诊断结节良恶性的受试者操作特征曲线。A1组(图a)甲状腺结节最大径<10 mm,A2组(图b)甲状腺结节最大径为10~20 mm,A3组(图c)甲状腺结节最大径>20 mm 注:C-TIRADS为中国甲状腺超声报告与数据系统
表3 C-TIRADS评分和分类系统诊断甲状腺结节良恶性的最佳临界值及诊断效能
1
Hyun MK, Kim JH, Kwon JW. Incidence of thyroid cancer and medical cost among patients with newly diagnosed thyroid nodules in Korea: a retrospective cohort study using nationwide data [J]. J Cancer Res Ther, 2019, 15(3): 676-680.
2
Wang J, Yu F, Shang Y, et al. Thyroid cancer: incidence and mortality trends in China, 2005-2015 [J]. Endocrine, 2020, 68(1): 163-173.
3
Grani G, Sponziello M, Pecce V, et al. Contemporary thyroid nodule evaluation and management [J]. J Clin Endocrinol Metab, 2020, 105(9): 2869-2883.
4
Zhou J, Yin L, Wei X, et al. 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS [J]. Endocrine, 2020, 70(2): 256-279.
5
Chen X, Gao M, Hu L, et al. The diagnostic value of the ultrasound gray scale ratio for different sizes of thyroid nodules [J]. Cancer Med, 2019, 8(18): 7644-7649.
6
Zhang S, Huang L, Huang Q, et al. The value of relative size in the ultrasound diagnosis of follicular thyroid neoplasm [J]. Int J Gen Med, 2021, 14: 2321-2328.
7
陈峰, 夏结来. 临床试验统计学 [M]. 北京: 人民卫生出版社, 2018: 358-376.
8
刘志艳, 周庚寅, KakudoKennichi, 等. 2017版WHO甲状腺肿瘤分类解读 [J]. 中华病理学杂志, 2018, 47(4): 302-306.
9
Zhao L, Dias-Santagata D, Sadow PM, et al. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma [J]. Cancer Cytopathol, 2017, 125(5): 323-331.
10
Tessler FN, Middleton WD, Grant EG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee [J]. J Am Coll Radiol, 2017, 14(5): 587-595.
11
薛坤, 齐铮琴, 史文宗, 等. 甲状腺微小乳头状癌超声特征与淋巴结转移的分析 [J]. 中国超声医学杂志, 2020, 36(4): 306-309.
12
Li QL, Ma T, Wang ZJ, et al. The value of contrast-enhanced ultrasound for the diagnosis of metastatic cervical lymph nodes of papillary thyroid carcinoma: A systematic review and meta-analysis [J]. J Clin Ultrasound, 2022, 50(1): 60-69.
13
Tian X, Song Q, Xie F, et al. Papillary thyroid carcinoma: an ultrasound-based nomogram improves the prediction of lymph node metastases in the central compartment [J]. Eur Radiol, 2020, 30(11): 5881-5893.
14
Peng Q, Niu C, Zhang M, et al. Sonographic characteristics of papillary thyroid carcinoma with coexistent Hashimoto's thyroiditis: conventional ultrasound, acoustic radiation force impulse imaging and contrast-enhanced ultrasound [J]. Ultrasound Med Biol, 2019, 45(2): 471-480.
15
Thomas CM, Asa SL, Ezzat S, et al. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines [J]. Curr Oncol, 2019, 26(5): 338-344.
16
Tajiri K, Hirokawa M, Suzuki A, et al. Can ultrasound alone predict papillary thyroid carcinoma with desmoid-type fibromatosis? A retrospective analysis of 13 cases, focusing on the stromal area [J]. Ultrasound Int Open, 2018, 4(2): 39-44.
17
Peng Y, Zhou W, Zhan WW, et al. Ultrasonographic assessment of differential diagnosis between degenerating cystic thyroid nodules and papillary thyroid microcarcinomas [J]. World J Surg, 2017, 41(10): 2538-2544.
18
Ou D, Yao J, Jin J, et al. Ultrasonic identification and regression analysis of 294 thyroid follicular tumors [J]. J Cancer Res Ther, 2020, 16(5): 1056-1062.
19
Xu B, Ghossein RA. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): an update [J]. Head Neck Pathol, 2020, 14(2): 303-310.
20
张玮婧, 张捷, 彭娟, 等. 超声综合评分法在不同大小甲状腺结节良恶性鉴别诊断中的价值 [J]. 临床超声医学杂志, 2015, 17(1): 21-23.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 李晓妮, 卫青, 孟庆龙, 牛丽莉, 田月, 吴伟春, 朱振辉, 王浩. 超声心动图在孤立性左心室心尖发育不良疾病中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 937-942.
[3] 陈慧, 姚静, 张宁, 刘磊, 马秀玲, 王小贤, 方爱娟, 管静静. 超声心动图在多发性骨髓瘤心脏淀粉样变中的诊断价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 943-949.
[4] 戴飞, 赵博文, 潘美, 彭晓慧, 陈冉, 田园诗, 狄敏. 胎儿心脏超声定量多参数对主动脉缩窄胎儿心脏结构及功能的诊断价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 950-958.
[5] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[6] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[7] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[8] 包艳娟, 杨小红, 张涛, 赵胜, 张莉. 阴道斜隔综合征的超声诊断与临床分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 859-864.
[9] 汪洪斌, 张红霞, 何文, 杜丽娟, 程令刚, 张雨康, 张萌. 低级别阑尾黏液性肿瘤与阑尾黏液腺癌超声及超声造影特征分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 865-871.
[10] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[11] 刘思锐, 赵辰阳, 张睿, 张一休, 杨萌. 多普勒超声对孕鼠子宫动脉不同节段血流动力学参数的评估[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 877-883.
[12] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[13] 宋勇, 李东炫, 王翔, 李锐. 基于数据挖掘法分析3 种超声造影剂不良反应信号[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 890-898.
[14] 张晓燕, 武玺宁, 张一休, 刘真真, 孝梦甦, 李建初. 超声医学科人文素养教育提升医患沟通能力的调查分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 899-903.
[15] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?